# Getty Realty Corp: financial statements, quarterly

GTY · NYSE · CIK 1052752 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gty.md) · [Financials](/companies/gty/financials.md) · [Filings](/companies/gty/filings.md) · [Insiders](/companies/gty/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gty/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [47.6 d](/filings/0001193125-26-048965.md) | [49.0](/filings/0000950170-25-058063.md) | [49.9](/filings/0000950170-25-098370.md) | [51.5](/filings/0001193125-25-248819.md) | [53.0 d](/filings/0001193125-26-048965.md) | [52.3](/filings/0001193125-26-173827.md) | [53.3](/filings/0001193125-26-314247.md) | [55.6](/filings/0001193125-26-428988.md) | [60.5 d](/filings/0001193125-26-048965.md) | [57.8](/filings/0001193125-26-173827.md) | [59.1](/filings/0001193125-26-314247.md) | [63.0](/filings/0001193125-26-428988.md) |
| Operating income | $m | [25.1 d](/filings/0001193125-26-048965.md) | [25.7](/filings/0000950170-25-058063.md) | [26.2](/filings/0000950170-25-098370.md) | [25.2](/filings/0001193125-25-248819.md) | [32.7 d](/filings/0001193125-26-048965.md) | [26.4](/filings/0001193125-26-173827.md) | [24.9](/filings/0001193125-26-314247.md) | [34.8](/filings/0001193125-26-428988.md) | [40.7 d](/filings/0001193125-26-048965.md) | [38.3](/filings/0001193125-26-173827.md) | [34.9](/filings/0001193125-26-314247.md) | [38.9](/filings/0001193125-26-428988.md) |
| Interest expense | $m | [8.8 d](/filings/0001193125-26-048965.md) | [9.1](/filings/0000950170-25-058063.md) | [9.7](/filings/0000950170-25-098370.md) | [10.1](/filings/0001193125-25-248819.md) | [10.4 d](/filings/0001193125-26-048965.md) | [11.7](/filings/0001193125-26-173827.md) | [10.9](/filings/0001193125-26-314247.md) | [11.5](/filings/0001193125-26-428988.md) | [12.3 d](/filings/0001193125-26-048965.md) | [12.0](/filings/0001193125-26-173827.md) | [12.3](/filings/0001193125-26-314247.md) | [13.4](/filings/0001193125-26-428988.md) |
| Net income | $m | [16.5 d](/filings/0001193125-26-048965.md) | [16.7](/filings/0000950170-25-058063.md) | [16.7](/filings/0000950170-25-098370.md) | [15.3](/filings/0001193125-25-248819.md) | [22.3 d](/filings/0001193125-26-048965.md) | [14.8](/filings/0001193125-26-173827.md) | [14.0](/filings/0001193125-26-314247.md) | [23.3](/filings/0001193125-26-428988.md) | [27.0 d](/filings/0001193125-26-048965.md) | [26.6](/filings/0001193125-26-173827.md) | [22.6](/filings/0001193125-26-314247.md) | [25.6](/filings/0001193125-26-428988.md) |
| Diluted EPS | $ per share | not reported | [0.30](/filings/0000950170-25-058063.md) | [0.30](/filings/0000950170-25-098370.md) | [0.27](/filings/0001193125-25-248819.md) | not reported | [0.25](/filings/0001193125-26-173827.md) | [0.24](/filings/0001193125-26-314247.md) | [0.40](/filings/0001193125-26-428988.md) | not reported | [0.43](/filings/0001193125-26-173827.md) | [0.36](/filings/0001193125-26-314247.md) | [0.40](/filings/0001193125-26-428988.md) |
| Basic EPS | $ per share | not reported | [0.30](/filings/0000950170-25-058063.md) | [0.30](/filings/0000950170-25-098370.md) | [0.27](/filings/0001193125-25-248819.md) | not reported | [0.25](/filings/0001193125-26-173827.md) | [0.24](/filings/0001193125-26-314247.md) | [0.40](/filings/0001193125-26-428988.md) | not reported | [0.43](/filings/0001193125-26-173827.md) | [0.36](/filings/0001193125-26-314247.md) | [0.40](/filings/0001193125-26-428988.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.3](/filings/0000950170-25-019976.md) | [10.7](/filings/0000950170-24-049250.md) | [4.7](/filings/0000950170-24-086604.md) | [4.0](/filings/0000950170-24-117098.md) | [9.5](/filings/0001193125-26-048965.md) | [6.3](/filings/0000950170-25-058063.md) | [7.5](/filings/0000950170-25-098370.md) | [5.2](/filings/0001193125-25-248819.md) | [8.4](/filings/0001193125-26-428988.md) | [3.7](/filings/0001193125-26-173827.md) | [4.8](/filings/0001193125-26-314247.md) | [8.8](/filings/0001193125-26-428988.md) |
| Total assets | $m | [1,822](/filings/0000950170-25-019976.md) | [1,850](/filings/0000950170-24-049250.md) | [1,892](/filings/0000950170-24-086604.md) | [1,902](/filings/0000950170-24-117098.md) | [1,974](/filings/0001193125-26-048965.md) | [1,970](/filings/0000950170-25-058063.md) | [2,015](/filings/0000950170-25-098370.md) | [2,056](/filings/0001193125-25-248819.md) | [2,173](/filings/0001193125-26-428988.md) | [2,180](/filings/0001193125-26-173827.md) | [2,291](/filings/0001193125-26-314247.md) | [2,572](/filings/0001193125-26-428988.md) |
| Total liabilities | $m | [867](/filings/0000950170-25-019976.md) | [899](/filings/0000950170-24-049250.md) | [941](/filings/0000950170-24-086604.md) | [938](/filings/0000950170-24-117098.md) | [1,012](/filings/0001193125-26-048965.md) | [1,009](/filings/0000950170-25-058063.md) | [1,033](/filings/0000950170-25-098370.md) | [1,044](/filings/0001193125-25-248819.md) | [1,101](/filings/0001193125-26-428988.md) | [1,090](/filings/0001193125-26-173827.md) | [1,169](/filings/0001193125-26-314247.md) | [1,294](/filings/0001193125-26-428988.md) |
| Long-term debt | $m | [755](/filings/0000950170-25-019976.md) | [795](/filings/0000950170-24-049250.md) | [838](/filings/0000950170-24-086604.md) | [834](/filings/0000950170-24-117098.md) | [904](/filings/0001193125-26-048965.md) | [901](/filings/0000950170-25-058063.md) | [919](/filings/0000950170-25-098370.md) | [935](/filings/0001193125-25-248819.md) | [995](/filings/0001193125-26-428988.md) | [994](/filings/0001193125-26-173827.md) | [1,067](/filings/0001193125-26-314247.md) | [1,194](/filings/0001193125-26-428988.md) |
| Shareholders' equity | $m | [956](/filings/0001193125-26-048965.md) | [950](/filings/0000950170-25-098370.md) | [951](/filings/0001193125-25-248819.md) | [963](/filings/0001193125-25-248819.md) | [962](/filings/0001193125-26-428988.md) | [961](/filings/0001193125-26-314247.md) | [982](/filings/0001193125-26-428988.md) | [1,012](/filings/0001193125-26-428988.md) | [1,072](/filings/0001193125-26-428988.md) | [1,089](/filings/0001193125-26-314247.md) | [1,123](/filings/0001193125-26-428988.md) | [1,278](/filings/0001193125-26-428988.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [30.8 d](/filings/0001193125-26-048965.md) | [30.0](/filings/0000950170-25-058063.md) | [29.7 d](/filings/0000950170-25-098370.md) | [34.6 d](/filings/0001193125-25-248819.md) | [36.2 d](/filings/0001193125-26-048965.md) | [28.7](/filings/0001193125-26-173827.md) | [34.7 d](/filings/0001193125-26-314247.md) | [30.5 d](/filings/0001193125-26-428988.md) | [33.5 d](/filings/0001193125-26-048965.md) | [33.1](/filings/0001193125-26-173827.md) | [41.7 d](/filings/0001193125-26-314247.md) | [31.2 d](/filings/0001193125-26-428988.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [23.2 d](/filings/0001193125-26-048965.md) | [24.8](/filings/0000950170-25-058063.md) | [24.9 d](/filings/0000950170-25-098370.md) | [25.0 d](/filings/0001193125-25-248819.md) | [25.4 d](/filings/0001193125-26-048965.md) | [26.5](/filings/0001193125-26-173827.md) | [26.8 d](/filings/0001193125-26-314247.md) | [27.4 d](/filings/0001193125-26-428988.md) | [27.9 d](/filings/0001193125-26-048965.md) | [29.8](/filings/0001193125-26-173827.md) | [30.2 d](/filings/0001193125-26-314247.md) | [30.9 d](/filings/0001193125-26-428988.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [47.6](/filings/0000950170-24-049250.md) | [50.0](/filings/0000950170-24-086604.md) | [50.7](/filings/0000950170-24-117098.md) | [54.0](/filings/0000950170-25-058063.md) | [54.0](/filings/0000950170-25-098370.md) | [54.6](/filings/0001193125-25-248819.md) | [55.2](/filings/0001193125-26-173827.md) | [55.6](/filings/0001193125-26-314247.md) | [56.8](/filings/0001193125-26-428988.md) | [59.9](/filings/0001193125-26-173827.md) | [60.7](/filings/0001193125-26-314247.md) | [62.6](/filings/0001193125-26-428988.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 67,123,711 at 2026-10-22, from the cover of the [10-Q filed 2026-10-22](/filings/0001193125-26-428988.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.